Completeness of RET testing in patients with medullary thyroid carcinoma in Denmark 1997–2013: a nationwide study

References

• MathiesenJSKroustrupJPVestergaardPIncidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide studyEndocr Connect20187682983929760189
   PubMed Web of Science ®Google Scholar
• RaueFKotzerkeJReinweinDPrognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma RegisterClin Investig1993711712
   PubMedGoogle Scholar
• WellsSAAsaSLDralleHRevised American Thyroid Association guidelines for the management of medullary thyroid carcinomaThyroid201525656761025810047
   PubMed Web of Science ®Google Scholar
• FinkMWeinhüselANiederleBHaasOADistinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. “Study Group Multiple Endocrine Neoplasia Austria (SMENA)”Int J Cancer19966943123168797874
   PubMed Web of Science ®Google Scholar
• BrandiMLGagelRFAngeliAGuidelines for diagnosis and therapy of MEN type 1 and type 2J Clin Endocrinol Metab200186125658567111739416
   PubMed Web of Science ®Google Scholar
• American Thyroid Association Guidelines Task ForceKloosRTEngCMedullary thyroid cancer: management guidelines of the American Thyroid AssociationThyroid200919656561219469690
   PubMed Web of Science ®Google Scholar
• ParkhurstECalonicoEAbboySUtilization of genetic testing for RET mutations in patients with medullary thyroid carcinoma: a single-center experienceJ Genet Couns20182761411141629951718
   PubMed Web of Science ®Google Scholar
• MathiesenJSKroustrupJPVestergaardPDistribution of RET mutations in multiple endocrine Neoplasia 2 in Denmark 1994-2014: a nationwide studyThyroid201727221522327809725
   PubMed Web of Science ®Google Scholar
• AndersenPHKroustrupJPFeldt-RasmussenUFMultipel endokrin neoplasi: Screening, diagnostik, behandling og efterkontrol: Oversigt og vejledende retningslinjer udarbejdet af Dansk MEN-arbejdsgruppe under Dansk Endokrinologisk SelskabLægeforeningens forlag2002
   Google Scholar
• GjerstorffMLThe Danish Cancer RegistryScand J Public Health2011397 Suppl424521775350
   PubMed Web of Science ®Google Scholar
• LonderoSCMathiesenJSKrogdahlACompleteness and validity in a national clinical thyroid cancer database: DATHYRCACancer Epidemiol201438563363725132423
   PubMed Web of Science ®Google Scholar
• ErichsenRLashTLHamilton-DutoitSJBjerregaardBVybergMPedersenLExisting data sources for clinical epidemiology: the Danish National Pathology Registry and Data BankClin Epidemiol20102515620865103
   PubMedGoogle Scholar
• MathiesenJSKroustrupJPVestergaardPIncidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide studyEndocr Relat Cancer2017247L39L4228438782
   PubMed Web of Science ®Google Scholar
• EdgeSBByrdDRComptonCCAJCC Cancer Staging Manual7th edNew York, NYSpringer2010
   Google Scholar
• AminMBEdgeSBGreeneFLAJCC Cancer Staging Manual8th edNew York, NYSpringer2017
   Google Scholar
• MathiesenJSKroustrupJPVestergaardPFounder Effect of the RETC611Y Mutation in Multiple Endocrine Neoplasia 2A in Denmark: a Nationwide StudyThyroid201727121505151029020875
   PubMed Web of Science ®Google Scholar
• GodballeCJørgensenGGerdesAMKrogdahlASTybjaerg-HansenANielsenFCMedullary thyroid cancer: RET testing of an archival materialEur Arch Otorhinolaryngol2010267461361719823860
   PubMed Web of Science ®Google Scholar
• MathiesenJSDossingHBenderLMedullary thyroid carcinoma in a 10-month-old child with multiple endocrine neoplasia 2BUgeskr Laeger20141765apii
   Google Scholar
• EmmertsenKScreening for hereditary medullary cancer in DenmarkHenry Ford Hosp Med J19843242382436152458
   PubMedGoogle Scholar
• MathiesenJSHabraMABassettJHDRisk profile of the RET A883F germline mutation: an international collaborative studyJ Clin Endocrinol Metab201710262069207428323957
   PubMed Web of Science ®Google Scholar
• MathiesenJSStochholmKPoulsenPLVestergaardEMChristiansenPVestergaardPAggressive medullary thyroid carcinoma in a ten-year-old patient with multiple endocrine neoplasia 2B due to the A883F mutationThyroid201525113914025244518
   PubMed Web of Science ®Google Scholar
• VestergaardPKroustrupJPRønneHEngCLaurbergPNeuromas in multiple endocrine neoplasia type 2A with a RET codon 611 mutationJ Endocr Genet1999113337
   Google Scholar
• HansenHSTorringHGodballeCJägerACNielsenFCIs thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?Cancer200089486386710951350
   PubMed Web of Science ®Google Scholar
• MathiesenJSKroustrupJPVestergaardPIncidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901-2014: a nationwide studyClin Epidemiol2018101479148730349395
   PubMed Web of Science ®Google Scholar
• KwonHKimWGSungTYChanging trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinomaJ Surg Oncol2016113215215826799259
   PubMed Web of Science ®Google Scholar
• KwonHKimWGJeonMJDynamic risk stratification for medullary thyroid cancer according to the response to initial therapyEndocrine201653117418126754662
   PubMed Web of Science ®Google Scholar
• ChoYYJangHWJangJYClinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrenceHead Neck201638101501150827062421
   PubMed Web of Science ®Google Scholar
• WeiszGCambrosioAKeatingPKnaapenLSchlichTTournayVJThe emergence of clinical practice guidelinesMilbank Q200785469172718070334
   PubMed Web of Science ®Google Scholar
• Donis-KellerHDouSChiDMutations in the RET proto-oncogene are associated with MEN 2A and FMTCHum Mol Genet1993278518568103403
   PubMed Web of Science ®Google Scholar
• MulliganLMKwokJBHealeyCSGerm-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature199336364284584608099202
   PubMed Web of Science ®Google Scholar
• CarlsonKMDouSChiDSingle missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2BProc Natl Acad Sci USA1994914157915837906417
   PubMed Web of Science ®Google Scholar
• EngCSmithDPMulliganLMPoint mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumoursHum Mol Genet1994322372417911697
   PubMed Web of Science ®Google Scholar
• HofstraRMLandsvaterRMCeccheriniIA mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinomaNature199436764613753767906866
   PubMed Web of Science ®Google Scholar
• PanigrahiBRomanSASosaJAMedullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?Ann Surg Oncol20101761490149820224861
   PubMed Web of Science ®Google Scholar
• KuoEJShoSLiNZanoccoKAYehMWLivhitsMJRisk factors associated with reoperation and disease-specific mortality in patients with medullary thyroid carcinomaJAMA Surg20181531525928973144
   PubMed Web of Science ®Google Scholar
• MathiesenJSKroustrupJPVestergaardPReplication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide studyEndocr Connect Epub2018121
   Web of Science ®Google Scholar
• MathiesenJSKroustrupJPVestergaardPSurvival and long-term biochemical cure in medullary thyroid carcinoma in Denmark 1997–2014: A nationwide studyThyroid2019
   Web of Science ®Google Scholar